Progesterone Dosing Regimens for Irregular Bleeding
For irregular uterine bleeding, the recommended first-line progesterone regimen is oral medroxyprogesterone acetate 10 mg daily for 10-14 days per cycle, or micronized progesterone 200 mg daily for 12-14 days every 28 days. 1, 2
First-Line Treatment Options
Oral Progesterone Options:
- Medroxyprogesterone acetate (MPA): 10 mg daily for 10-14 days beginning on day 16 of each cycle 1, 3
- Micronized progesterone (MP): 200 mg daily for 12-14 days every 28 days 2
Alternative Delivery Methods:
- Vaginal progesterone: Micronized progesterone 200 mg daily for 12-14 days every 28 days 2
- Levonorgestrel-releasing IUD: Most effective option with up to 97% reduction in bleeding by 6 months 1, 3
Treatment Selection Algorithm
Determine if contraception is required:
Determine patient preference regarding withdrawal bleeding:
- If withdrawal bleeding acceptable: Use cyclic progesterone regimen
- If withdrawal bleeding not desired: Use continuous combined regimen 2
Select appropriate regimen based on severity:
- For mild-moderate bleeding: Oral/vaginal progesterone for 10-14 days per cycle
- For severe bleeding: Consider levonorgestrel IUD or continuous combined therapy 1
Dosing Specifics by Scenario
For Cyclic Therapy (with withdrawal bleeding):
- Transdermal 17β-estradiol (if estrogen needed) administered continuously
- Add oral progesterone (MPA 10 mg daily or MP 200 mg daily) for 12-14 days every 28 days 2
For Continuous Therapy (avoiding withdrawal bleeding):
- Combined tablets containing estradiol and progestin administered continuously
- Example: 1-2 mg estradiol with 5 mg dydrogesterone or 2 mg dienogest 2
Efficacy Considerations
The levonorgestrel-releasing IUD is significantly more effective than oral medroxyprogesterone acetate for treating heavy menstrual bleeding:
- LNG-IUD reduces menstrual blood loss by median of 128.8 mL
- Oral MPA reduces menstrual blood loss by median of only 17.8 mL
- Success rates: 84.8% for LNG-IUD vs 22.2% for oral MPA 3
Common Side Effects and Management
- Breakthrough bleeding: Common with progestin-only methods, especially in first 3-6 months 4
- Amenorrhea: Occurs in approximately 50% of LNG-IUD users by 2 years (expected effect) 1
- Drowsiness: Can occur with oral micronized progesterone; administering at bedtime minimizes this effect 5
- Iron deficiency: Consider iron supplementation if bleeding is heavy or prolonged 1
Important Caveats
- Higher doses of medroxyprogesterone acetate (50 mg daily) may be needed for conditions like endometriosis but are not typically used for irregular bleeding alone 6
- Women with excessive bleeding unresponsive to medical therapy should undergo endometrial biopsy to rule out underlying pathology 1
- Consider structural causes of bleeding (polyps, fibroids) if response to hormonal therapy is inadequate 1
- Micronized progesterone may have fewer metabolic and vascular side effects compared to synthetic progestins 5